http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#Head http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#assertion http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#provenance http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#pubinfo http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#assertion http://purl.obolibrary.org/obo/DOID_9074 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/DOID_9074 http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://identifiers.org/drugbank:DB01611 http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association http://www.w3.org/2000/01/rdf-schema#label malaria hydroxychloroquine sulfate tablets are indicated for the treatment of uncomplicated malaria due to p falciparum p malariae p ovale p vivax hydroxychloroquine sulfate tablets are indicated for the prophylaxis of malaria in geographic areas where chloroquine resistance is not reported limitations of use in malaria hydroxychloroquine sulfate tablets are not recommended for the treatment of complicated malaria hydroxychloroquine sulfate tablets are not effective against chloroquine or hydroxychloroquine resistant strains of plasmodium clinical pharmacology microbiology plasmodium hydroxychloroquine sulfate tablets are not recommended for malaria prophylaxis in geographic areas where chloroquine resistance occurs hydroxychloroquine sulfate tablets do not prevent relapses of p vivax p ovale p vivax p ovale clinical pharmacology microbiology prior to prescribing hydroxychloroquine sulfate tablets for the treatment or prophylaxis of malaria consult the centers for disease control and prevention cdc malaria website http www cdc gov malaria lupus erythematosus hydroxychloroquine sulfate tablets are indicated for the treatment of chronic discoid lupus erythematosus and systemic lupus erythematosus in adults rheumatoid arthritis hydroxychloroquine sulfate tablets are indicated for the treatment of acute and chronic rheumatoid arthritis in adults http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#association https://w3id.org/biolink/vocab/relation https://schema.org/TreatmentIndication https://identifiers.org/drugbank:DB01611 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#provenance http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#pubinfo http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig http://purl.org/nanopub/x/hasSignature co5nkSVsbhNLqGDvAqEb0SYKaqorWrt5qvHS58xQ+W82Cr+slLAU1ynuvceE/TacPT1qEn+mJQfd38IQjA7b7HgTF8w0sDHjgd4IBRJPbNZH6F8ERhewSd+W3py6Uo9pkr4ldgcGQD5+guRxjZ0Jx1364r51klEYiKx2v/rbHW4= http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY http://purl.org/dc/terms/created 2021-06-15T18:42:22.763+02:00 http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY http://purl.org/dc/terms/creator https://orcid.org/0000-0002-1468-3557 http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAmSk5GdhM0lAeqPZRD7SuwVntMIsK4rKkGY7ebvRmvaY https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs